Presentations
2014
  • Importance of medicines reconciliation in disharge planning

    December 2014
    Canadian Alternate Level of Care Conference, Toronto, Canada

    Visante’s senior consultant, Cynthia Hennen (RPh) will discuss medicines reconciliation programs and its implications for readmission rates, resource allocation and complex care management.

  • Formulary considerations with biosimilars

    November 2014
    Jeddah, Saudi Arabia

    A lecture by Visante’s James Stevenson, PharmD, FASHP at the “Exploring a new horizon in pharmacy practise in Saudi Arabia” conference.  This was organised in collaboration with the American Society of Health Systems Pharmacists by the Ministry of National Guard – Health Affairs, King Saud Bin Abdulaziz University for Health Science – Jeddah, King Abdulaziz Medical City, Western Region.

  • Evidence-based review process for formulary drug addition

    November 2014
    Jeddah, Saudi Arabia

    A lecture by Visante’s James Stevenson, PharmD, FASHP at the “Exploring a new horizon in pharmacy practise in Saudi Arabia” conference.  This was organised in collaboration with the American Society of Health Systems Pharmacists by the Ministry of National Guard – Health Affairs, King Saud Bin Abdulaziz University for Health Science – Jeddah, King Abdulaziz Medical City, Western Region.

  • Pharmacy and therapeutics committees: effective approaches to formulary drug evaluation and drug policy

    November 2014
    Jeddah, Saudi Arabia

    A workshop led by Visante’s James Stevenson, PharmD, FASHP at the “Exploring a new horizon in pharmacy practise in Saudi Arabia” conference.  This was organised in collaboration with the American Society of Health Systems Pharmacists by the Ministry of National Guard – Health Affairs, King Saud Bin Abdulaziz University for Health Science – Jeddah, King Abdulaziz Medical City, Western Region.

  • Formulary decision-making: beyond evidence

    November 2014
    King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

    An invited presentation by Visante, Inc. and Visante Ltd hospital and health systems services president, James Stevenson (PharmD, FASHP), at the Drug Formulary Management Concept, Theory and Practice: Beyond Drug Selection Symposium.

  • Integrating pharmacy and therapeutics decisions within health care information systems

    November 2014
    King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

    An invited presentation by Visante, Inc. and Visante Ltd hospital and health systems services president, James Stevenson (PharmD, FASHP), at the Drug Formulary Management Concept, Theory and Practice: Beyond Drug Selection Symposium.

  • Economic evaluation as a component of formulary decision-making

    November 2014
    King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

    An invited presentation by Visante, Inc. and Visante Ltd hospital and health systems services president, James Stevenson (PharmD, FASHP), at the Drug Formulary Management Concept, Theory and Practice: Beyond Drug Selection Symposium.

  • Team-based care to optimise medicines outcomes for chronic conditions

    October 2014
    Virginia Commonwealth University School of Pharmacy

    An invited presentation by Visante, Inc. and Visante Ltd hospital and health systems services president, James Stevenson (PharmD, FASHP)

  • Hazardous medicines handling: Safety with savings

    September 2014
    Asian Pacific Oncology Pharmacy Conference, Seoul, Korea

    September 30, 2014

    A presentation by James Jorgenson (M.S., RPh), Visante Inc. CEO and Board Chair Visante Ltd, Visante Canada, and Visante UK. Jorgenson will discuss the advantages of closed system technology when handling hazardous medicines in terms of employee safety and savings gained by extending the use of remaining doses through drug vial optimisation (DVO).

  • Formulary considerations with biosimilars

    September 2014
    FIP Meeting, Bangkok, Thailand

    A presentation on 2 September by James Stevenson (Pharm D, FASHP), President Hospital & Health Systems Services, Visante, Inc. and Visante, Ltd. This address was part of the overall discussion of insights into biosimilars and non-biological complex drugs at the International Pharmaceutical Federation (FIP) meeting.